x

Anticoagulant therapy, pregnancy, venous thromboembolism (VTE), pulmonary embolism, hypercoagulable state, low molecular weight heparin (LMWH), unfractionated heparin (UFH), warfarin, direct oral anticoagulants (DOACs), thrombophilia, Factor V Leiden mutation, prothrombin gene mutation, placental insufficiency, maternal morbidity, maternal mortality, thrombosis prevention, anti-Xa monitoring, postpartum thrombosis, obstetric complications.

American College of Obstetricians and Gynecologists (ACOG). Thromboembolism in pregnancy. Practice Bulletin No. 196. Obstet Gynecol. 2018;132(1):e1–e17.

Royal College of Obstetricians and Gynaecologists (RCOG). Reducing the risk of venous thromboembolism during pregnancy and the puerperium. Green-top Guideline No. 37a. London: RCOG; 2015 (updated guidance).

World Health Organization. WHO recommendations on antenatal care for a positive pregnancy experience. Geneva: WHO; 2016.

American Society of Hematology. American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy. Blood Adv. 2018;2(22):3317–3359.

Bates SM, Greer IA, Middeldorp S, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed. American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e691S–e736S.

European Society of Cardiology (ESC). ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018.

James AH. Venous thromboembolism in pregnancy. Arterioscler Thromb Vasc Biol. 2009;29(3):326–331.

National Institute for Health and Care Excellence (NICE). Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism. NICE guideline. London; 2020.